Advanced stem cell therapy for Parkinson's disease. MSC treatments target neurodegeneration, support dopaminergic pathways, and improve motor symptoms and quality of life.
Advanced stem cell therapy for Parkinson's disease at StemCell Longevita in Istanbul uses cutting-edge MSC protocols to protect dopamine neurons and slow disease progression. Our comprehensive Parkinson's program combines IV and intrathecal stem cell delivery with supportive neurorehabilitation for maximum therapeutic benefit.
Our advanced Parkinson's protocol targets multiple pathological mechanisms simultaneously. Wharton's jelly MSCs release GDNF and BDNF — neurotrophic factors essential for dopaminergic neuron survival. They suppress microglial overactivation that drives neuroinflammation, promote neural circuit repair, improve cerebral perfusion, and enhance synaptic plasticity. The intrathecal delivery route ensures direct access to the central nervous system, bypassing the blood-brain barrier for maximum neuroprotective effect.
Suitable for all Parkinson's stages, with strongest results in early-to-moderate disease. Also beneficial for patients with medication-resistant symptoms, "on-off" fluctuations, and those wishing to delay or avoid deep brain stimulation (DBS) surgery.
The program includes pre-treatment neurological assessment, combined IV + intrathecal MSC delivery, and may be combined with our Neuro-Rehabilitation Program for enhanced outcomes. Treatment in Istanbul takes 3-5 days with comprehensive monitoring throughout.
Improvements in UPDRS scores, tremor control, bradykinesia, rigidity, gait stability, and overall quality of life have been reported by our treated patients. Many experience reduced levodopa requirements. Benefits continue to develop over 6-12 months.
StemCell Longevita's neurological team includes specialists with specific expertise in movement disorders. Our GMP laboratory produces MSCs optimized for neuroprotective applications. Cost savings of 60-80% compared to US centers.
Advanced Parkinson's packages from €7,500-€12,000 depending on protocol complexity and combination with neuro-rehabilitation.
Related treatments: Dementia Stem Cell Therapy | Alzheimer's Disease Stem Cell Therapy | Multiple Sclerosis Stem Cell Therapy | Parkinson's Disease Stem Cell Therapy | Parkinson's Disease Latest Stem Cell Treatment